New-onset sexual dysfunction in men: cardiometabolic associations and a practical outpatient approach
Authors:
Marek Broul 1–3; Aneta Hujová 2; Michaela Liegertová 4; Jiří Škorpil 5
Authors‘ workplace:
Sexuologické oddělení, Masarykova nemocnice v Ústí nad Labem – Krajská zdravotní, a. s.
1; Fakulta zdravotnických studií UJEP v Ústí nad Labem
2; Urologické oddělení, Krajská zdravotní, a. s. - Nemocnice Litoměřice, o. z.
3; Přírodovědecká fakulta UJEP v Ústí nad Labem
4; Kardiochirurgická klinika, Masarykova nemocnice v Ústí nad Labem – Krajská zdravotní, a. s.
5
Published in:
Čas. Lék. čes. 2026; 165: 146-151
Category:
Review Article
Overview
New-onset sexual dysfunction in men, particularly erectile dysfunction, should not be regarded merely as an isolated sexual complaint. It may represent an early manifestation of endothelial dysfunction, atherosclerotic disease, diabetes mellitus type 2, obesity, arterial hypertension, dyslipidemia, hypogonadism, hyperprolactinemia, thyroid disorders, or adverse drug effects. The aim of this review is to summarize current evidence on the relationship between sexual dysfunction and cardiometabolic risk and to provide a practical outpatient approach for primary care, internal medicine, diabetology, urology, and sexual medicine.
This narrative review is based mainly on the current European Association of Urology recommendations, the Princeton IV Consensus, and selected systematic reviews and meta-analyses. Particular attention is paid to focused history taking, physical examination, basic laboratory work-up, risk stratification, and the differential diagnosis of vasculogenic, endocrine, iatrogenic, and psychogenic causes. The review also incorporates the Czech clinical context and proposes a pragmatic referral framework for situations requiring further evaluation or specialist care.
Keywords:
Sexual dysfunction – Erectile dysfunction – metabolic syndrome – cardiovascular diseases – type 2 diabetes mellitus – primary health care – hypogonadism – physiological
Sources
- Salonia A, Capogrosso P, Boeri L et al. European Association of Urology guidelines on male sexual and reproductive health: 2025 update on male hypogonadism, erectile dysfunction, premature ejaculation, and Peyronie’s disease. Eur Urol 2025; 88 : 76–102.
- Köhler TS, Kloner RA, Rosen RC et al. The Princeton IV Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc 2024; 99 : 1500–1517.
- Vlachopoulos CV, Terentes-Printzios DG, Ioakeimidis NK et al. Prediction of cardiovascular events and all-cause mortality with erectile dysfunction: a systematic review and meta-analysis of cohort studies. Circ Cardiovasc Qual Outcomes 2013; 6 : 99–109.
- Zhao B, Hong Z, Wei Y et al. Erectile dysfunction predicts cardiovascular events as an independent risk factor: a systematic review and meta-analysis. J Sex Med 2019; 16 : 1005–1017.
- Mulhall JP, Trost LW, Brannigan RE et al. Evaluation and management of testosterone deficiency: AUA Guideline. J Urol 2018; 200 : 423–432.
- Lincoff AM, Bhasin S, Flevaris P et al. Cardiovascular safety of testosterone-replacement therapy. N Engl J Med 2023; 389 : 107–117.
- Visseren FLJ, Mach F, Smulders YM et al. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 2021; 42 : 3227–3337.
- SCORE2 Working Group and ESC Cardiovascular Risk Collaboration. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J 2021; 42 : 2439–2454.
- SCORE2-OP Working Group and ESC Cardiovascular Risk Collaboration. SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in Europe. Eur Heart J 2021; 42 : 2455–2467.
- Montorsi P, Ravagnani PM, Galli S et al. The artery size hypothesis: a macrovascular link between erectile dysfunction and coronary artery disease. Am J Cardiol 2005; 96 (12B): 19M–23M.
- Mulhall JP, Goldstein I, Bushmakin AG et al. Validation of the Erection Hardness Score. J Sex Med 2007; 4 : 1626–1634.
- Rosen RC, Riley A, Wagner G et al. The International Index of Erectile Function: a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49 : 822–830.
- Rosen RC, Cappelleri JC, Smith MD et al. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999; 11 : 319–326.
- Broul M, Hujová A. Pozdní hypogonadismus u mužů starších 40 let – jak využít aktualizované doporučení EAU 2025 a nové poznatky o kardiovaskulární bezpečnosti testosteronové terapie. Čas Lék čes 2025; 164 : 150–155.
- Broul M, Kučerová P, Jozífková E et al. Treatment of thyroid disorder supported by 5-phosphodiesterase inhibitors improved erectile dysfunction in patients with hypo - and hyperthyroidism. Neuro Endocrinol Lett 2024; 45 : 180–187.
- Broul M, Hujová A, Radovnická L et al. Hyperprolactinemia-associated erectile dysfunction: retrospective cohort evaluating the effect of prolactin normalization on IIEF-5. Neuro Endocrinol Lett 2025; 46 : 107–114.
- Lou IX, Chen J, Ali K et al. Relationship between hypertension, antihypertensive drugs and sexual dysfunction in men and women: a literature review. Vasc Health Risk Manag 2023; 19 : 691–705.
Labels
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental HygienistArticle was published in
Journal of Czech Physicians
Most read in this issue
- New-onset sexual dysfunction in men: cardiometabolic associations and a practical outpatient approach
- Effects of different types of ionizing radiation on DNA from the perspective of medicine and planned piloted interplanetary flights
- New paradigm of therapeutic antibiotic monitoring
- et al. Radiation emergency – guidelines for the public